EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Scope & Guideline

Illuminating the Path of Molecular Imaging Discoveries

Introduction

Explore the comprehensive scope of EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1619-7070
PublisherSPRINGER
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1996 to 1997, 1999, from 2001 to 2024
AbbreviationEUR J NUCL MED MOL I / Eur. J. Nucl. Med. Mol. Imaging
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The European Journal of Nuclear Medicine and Molecular Imaging focuses on advancing the field of nuclear medicine through the publication of high-quality research articles that explore the application of molecular imaging and radiopharmaceutical therapies in clinical practice. This journal serves as a platform for disseminating cutting-edge developments in imaging technologies, therapeutic applications, and innovative methodologies.
  1. Theranostics in Cancer Treatment:
    The journal emphasizes the integration of diagnostics and therapeutics, particularly in oncology, highlighting studies on radioligand therapy and personalized treatment strategies for various cancers.
  2. Advancements in Molecular Imaging Techniques:
    It covers innovative imaging methods, including PET, SPECT, and hybrid imaging modalities, showcasing the latest technological advancements and their clinical implications.
  3. Radiopharmaceutical Development and Application:
    The journal includes research on the synthesis, characterization, and clinical application of new radiopharmaceuticals, focusing on their efficacy and safety in diagnostics and therapy.
  4. Clinical Applications and Guidelines:
    It provides insights into clinical practices, including guidelines for the use of imaging in various medical conditions, and explores the role of molecular imaging in treatment decision-making.
  5. Artificial Intelligence and Machine Learning in Imaging:
    The journal discusses the integration of AI and machine learning in enhancing imaging analysis, improving diagnostic accuracy, and optimizing treatment planning.
The journal has identified several emerging themes that reflect the current trends in nuclear medicine and molecular imaging. These themes indicate a growing interest in innovative technologies and their applications in clinical settings.
  1. AI and Deep Learning in Imaging:
    The integration of artificial intelligence and deep learning techniques is increasingly prevalent in imaging analysis, enhancing diagnostic accuracy and workflow efficiency.
  2. Personalized Medicine and Dosimetry:
    There is a rising focus on personalized dosimetry approaches, which optimize treatment based on individual patient characteristics and tumor biology, particularly in radioligand therapy.
  3. Innovative Radiopharmaceuticals:
    Research on novel radiopharmaceuticals, especially those targeting specific biomarkers in tumors, is gaining momentum, highlighting advancements in theranostics.
  4. Total-body Imaging Technology:
    The development and application of total-body PET imaging technology are emerging as a significant trend, with studies exploring its advantages in various clinical scenarios.
  5. Patient-Centric Approaches in Nuclear Medicine:
    An increasing number of studies are focusing on patient experience and outcomes, emphasizing the importance of integrating patient perspectives in nuclear medicine practice.

Declining or Waning

While the journal continues to address a wide range of topics in nuclear medicine and molecular imaging, some areas of research have shown a decline in publication frequency. This trend may reflect shifts in research focus or advancements in technology that render certain topics less relevant.
  1. Traditional Imaging Techniques:
    There has been a noticeable decrease in studies focused solely on conventional imaging techniques, such as planar scintigraphy, as newer hybrid and molecular imaging methods gain prominence.
  2. Basic Science Research in Radiopharmaceuticals:
    Research articles centered on basic science aspects of radiopharmaceuticals, such as preclinical studies without direct clinical application, have seen reduced publication frequency in favor of more clinically oriented studies.
  3. Non-targeted Radiopharmaceutical Applications:
    The journal has published fewer articles related to the non-targeted applications of radiopharmaceuticals, indicating a shift towards targeted therapies and precision medicine.

Similar Journals

EJNMMI Research

Empowering Research, Transforming Radiology.
Publisher: SPRINGERISSN: 2191-219XFrequency: 1 issue/year

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

Hellenic Journal of Nuclear Medicine

Elevating Standards in Nuclear Medicine Research
Publisher: HELLENIC SOC NUCLEAR MEDICINEISSN: 1108-1430Frequency: 3 issues/year

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

Radiology-Imaging Cancer

Transforming Cancer Diagnosis through Advanced Imaging.
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-616XFrequency: 6 issues/year

Radiology-Imaging Cancer is a prestigious journal published by the Radiological Society of North America (RSNA), focusing on the critical intersection of radiology, oncology, and advanced imaging techniques. This journal stands out in its field with a commendable ranking in the Q2 category for Medicine (miscellaneous) and Oncology, and an impressive Q1 ranking in Radiology, Nuclear Medicine and Imaging, according to the 2023 quartiles. With an ISSN of 2638-616X, it serves as an essential platform for the dissemination of research that contributes to the understanding and improvement of cancer diagnosis and treatment. Its comprehensive scope encompasses a range of topics, from innovative imaging modalities to clinical applications in oncology, making it a valuable resource for researchers, clinicians, and students interested in the evolving field of cancer imaging. Despite being published in the United States, the journal aims for a global reach, catering to a wide audience dedicated to advancing medical science.

CANCER IMAGING

Pioneering Insights for Enhanced Cancer Care
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

American Journal of Nuclear Medicine and Molecular Imaging

Bridging Research and Clinical Practice in Imaging
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-8407Frequency: 6 issues/year

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Fostering Collaboration in the Evolving Landscape of Nuclear Medicine.
Publisher: EDIZIONI MINERVA MEDICAISSN: 1824-4785Frequency: 4 issues/year

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.

Revista Espanola de Medicina Nuclear e Imagen Molecular

Bridging Theory and Practice in Radiology Innovations
Publisher: ELSEVIER ESPANA SLUISSN: 2253-654XFrequency: 6 issues/year

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.

Molecular Imaging

Exploring New Dimensions in Molecular Medicine.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.

EUROPEAN RADIOLOGY

Exploring Innovations in Diagnostic Imaging
Publisher: SPRINGERISSN: 0938-7994Frequency: 12 issues/year

EUROPEAN RADIOLOGY, published by SPRINGER, stands as a prestigious international journal in the field of radiology, nuclear medicine, and imaging, with an impressive impact factor that underscores its significance among peers. With an ISSN of 0938-7994 and an E-ISSN of 1432-1084, this journal provides a platform for cutting-edge research and advancements in medical imaging from 1991 to 2024. Recognized as a Q1 journal in both general Medicine and the specialized Radiology category by 2023, EUROPEAN RADIOLOGY ranks an impressive #17 out of 333 in its field according to Scopus, placing it in the 95th percentile. While it does not currently offer Open Access options, the journal remains essential reading for researchers, professionals, and students striving to stay at the forefront of developments in diagnostic imaging and related technologies. By contributing to a comprehensive understanding of radiological practices, EUROPEAN RADIOLOGY plays a crucial role in shaping the future of medical diagnosis and patient care.

Iranian Journal of Radiology

Advancing Radiology Through Innovative Research
Publisher: BRIEFLANDISSN: 1735-1065Frequency: 4 issues/year

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.